Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide-formoterol treatment.

International journal of chronic obstructive pulmonary disease - 1 Jan 2017

Wang Cheng, Li Jun-Xiong, Tang Dang, Zhang Jian-Qing, Fang Li-Zhou, Fu Wei-Ping, Liu Ling, Dai Lu-Ming

Abstract excerpt

BACKGROUND: Metabolomics is the global unbiased analysis of all the small-molecule metabolites within a biological system. Metabolic profiling of different high-resolution computed tomography (HRCT) phenotypes of COPD patients before and after treatment may identify discriminatory metabolites that can serve as biomarkers and therapeutic agents. PATIENTS AND METHODS: 1H nuclear magnetic resonance spectroscopy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Adrenal Cortex Hormones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Adrenergic beta-2 Receptor Agonists

Share to Bronchodilator Agents

Share to Metabolomics

Share to Proton Magnetic Resonance Spectroscopy

Share to Pulmonary Disease, Chronic Obstructive

Share to Tomography, X-Ray Computed

Source

Open in PubMed Open full text

Identifiers

PMID: 29255358
DOI: 10.2147/COPD.S152134
PMCID: PMC5723127

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide-formoterol treatment.PMID 29255358Read ↗

Metabolomic profiling reveals distinct metabolic patterns and a potential circulating biomarker in pre-COPDSemantic proximity Read ↗

Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and 'frequent exacerbator' phenotype.Semantic proximity Read ↗

Multi-omics study on biomarker and pathway discovery of chronic obstructive pulmonary diseaseSemantic proximity Read ↗

Metabolomics in COPD.Semantic proximity Read ↗

Sputum metabolomic profiling revels metabolic pathways and signatures associated with inflammatory phenotypes in patients with asthmaSemantic proximity Read ↗

Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven ModulesSemantic proximity Read ↗

Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPDSemantic proximity Read ↗

Distinct Metabolic Signatures Linked to High-Resolution Computed Tomography Radiographic Phenotypes in Stable and Progressive Fibrotic Lung DiseaseSemantic proximity Read ↗

Pulmonary function parameters in high-resolution computed tomography phenotypes of chronic obstructive pulmonary disease.Semantic proximity Read ↗

Metabolomics in asthma: where do we stand?Semantic proximity Read ↗

Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography.Semantic proximity Read ↗

Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.